Whether TNK (tenecteplase) benefits patients with acute ischemic stroke treated within 4.5 to 24 hours remains uncertain, and no previous meta-analysis has differentiated between clinical settings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback